NDC 10019-080 – Eribulin Mesylate

Eribulin Mesylate .5 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC10019-080

Product details

Brand name
Eribulin Mesylate
Generic name
Eribulin Mesylate
Labeler
Baxter Healthcare Company
Dosage form
Injection
Route
Intravenous
Marketing category
ANDA · ANDA217250
Marketed since
October 1, 2024
Listing expires
December 31, 2027
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Eribulin Mesylate →

Package NDC codes (1)

Package NDCDescriptionSince
10019-080-011 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSEDec 1, 2024

Other Eribulin Mesylate products